Citations

CAL-101, A p110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-cell Malignancies, Inhibits PI3K Signaling and Cellular Viability

September 20, 2016
Flow CAST® - Kinase Inhibtion Assay Citation: Lannutti, B.J. et al. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011 Jan 13; 117(2): 591-594. PMID: 20959606. "We have thus described the biochemical and cellular activity of CAL-101, a selective and potent inhibitor of p110δ; such targeted
Read more

A Novel Turbidimetric Immunoassay for Fecal Calprotectin Optimized for Routine Chemistry Analyzers

September 20, 2016
BÜHLMANN fCAL® turbo Citation: Nilsen, T. et. al.  A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers. J Clin Lab Anal. 2016 Sep 15. PMID:27629827 The publication describes the technical performance of the turbidimetric assay on the cobas c501 and the Mindray BS-380. Highlight from this Publication Short assay time of 10 min with
Read more

High-Dose Rituximab and Anti-MAG-Associated Polyneuropathy

September 1, 2016

Anti-MAG Autoantibodies ELISA Citation: Renaud S et al.; High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology. 2006 Mar 14; 66(5):742-4. PMID:16534115

Read more

High-Dose Rituximab and Anti-MAG-Associated Polyneuropathy

September 1, 2016

Anti-MAG Autoantibodies ELISA Citation: Renaud S et al.; High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology. 2006 Mar 14; 66(5):742-4. PMID:16534115

Read more